Retraction

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1172/JCI81878
Additional Notes:

Stephanie Watkins responsible; JME 06/27/2017

Citations (68)

68
Total Citations
22
Post-Retraction
(32.4%)
38
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
2 Within 30 days
8 Within 1 year
10 After 2+ years
3393 Days since retraction (latest)
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Aug 2013
627 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Jul 2013
660 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Jun 2013
699 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Apr 2013
731 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Feb 2013
795 days before retraction
Paper citing Immunity to Murine Prostatic Tumors: Continuous Pr...
Unknown Authors
Unknown Journal
Published: Jan 2013
836 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Dec 2012
871 days before retraction
Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms
Stéphanie Demoulin, Michaël Herfs, Philippe Delvenne et al. (4 authors)
Journal of Leukocyte Biology
Published: Nov 2012
148 citations
905 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Oct 2012
929 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Oct 2012
942 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2012
959 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2012
972 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Aug 2012
1003 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Mar 2012
1135 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Jan 2012
1216 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Aug 2011
1369 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Jul 2011
1396 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Apr 2011
1491 days before retraction
Quick Stats
Total Citations: 68
Years Since Retraction: 10.6 years
Open Access: Yes
Last Checked: Never
Related Papers
Sorting protein VPS33B regulates exosomal autocrine signali…
The Journal of Clinical Investigation (JCI) • 74 citations
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulate…
The Journal of Clinical Investigation (JCI) • 82 citations
NK cell heparanase controls tumor invasion and immune surve…
The Journal of Clinical Investigation (JCI) • 94 citations
TIGIT predominantly regulates the immune response via regul…
The Journal of Clinical Investigation (JCI) • 521 citations
Host immunity contributes to the anti-melanoma activity of …
The Journal of Clinical Investigation (JCI) • 268 citations